The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,998,822.37 firm fixed price Small Business Innovation Research (SBIR) Phase II contract to Boundless Science, LLC, a small business, to develop an Acute Respiratory Distress Syndrome (ARDS) Oxygenation Device (AOD). The contract, which is set aside for small businesses, will fund research and development efforts by Boundless Science in Chapel Hill, North Carolina through October 2026. Boundless Science has received multiple research grants from the National Institutes of Health for the development of various medical devices, including those related to blood oxygenation, aerosol ventilation, and extracorporeal membrane oxygenation systems.
Generated 8/5/24, 9:05 AM